Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer

Archives of Surgery

Volumn 141, Issue 6, 2006, Pages 545-549

  Moraca, Robert J ^a   Low, Donald E ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BARRETT ESOPHAGUS; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; FEEDING BEHAVIOR; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEARTBURN; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAMUCOSAL CANCER; MALE; MORBIDITY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SHORT FORM 36; CANCER RISK; COMORBIDITY; ENDOSCOPIC MUCOSAL RESECTION; NOTE; PATIENT SELECTION; STOMACH EMPTYING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; COHORT STUDIES; COMORBIDITY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; POSTOPERATIVE PERIOD; QUALITY OF LIFE; TREATMENT OUTCOME;

PROTON PUMP INHIBITOR;

EID: 33745242981     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.141.6.545     Document Type: Review

References (29)

1. Sampliner RE. Practice guidelines on the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol. 1998;93:1028-1032.
2. Cameron AJ, Carpenter HA. Barrett's esophagus, high grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol. 1997;92:586-591.
3. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low and high risk patient subsets. Am J Gastroenterol. 2000;95:1669-1676.
4. Headrick JR, Nichols FC III, Miller DL, et al. High grade dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg. 2002;73:1697-1703.
5. Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC. Barrett's esophagus with high grade dysplasia: an indication for esophagectomy? Ann Thorac Surg. 1992;54:199-204.
6. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia: an indication for prophylactic esophagectomy. Ann Surg. 1996;224:66-71.
7. Al-kasspooles MF, Hill HC, Nava HR, Smith JL, Douglass HO, Gibbs JF. High grade dysplasia within Barrett's esophagus: controversies regarding clinical opinions and approaches. Ann Surg Oncol. 2002;9:222-227.
8. Ormsby AH, Petras RE, Henricks WH, et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut. 2002;51:671-676.
9. Scotiniotis IA, Kochman MI, Lewis JD, Furth EE, Rosato EF, Ginsberg GG. Accuracy of EUS in the evaluation of Barrett's esophagus and high grade dysplasia or intramucosal carcinoma. Gastrointest Endosc. 2001;54:689-696.
10. Edwards MJ, Gable DR, Lentsch AB, et al. The rationale for esophagectomy as the optimal therapy with high grade dysplasia. Ann Surg. 1996;223:585-591.
11. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical morbidity in the United States. N Engl J Med. 2002;346:1128-1137.
12. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280:1747-1751.
13. Patti MG, Corvera CU, Glasgow RE, Way LW. A hospital's annual rate of esophagectomy influences the operative mortality rate. J Gastrointest Surg. 1998;2:186-192.
14. Falk GW, Rice TW, Goldblum JR, Richter JE. Jumbo forceps protocol still misses unsuspected cancer in Barrett's esophagus with high grade dysplasia. Gastrointest Endosc. 1999;49:170-176.
15. Wang KK. Photodynamic therapy of Barrett's esophagus. Gastrointest Endosc Clin N Am. 2000;10:409-419.
16. Dumoulin FL, Terjung B, Neubrand M, et al. Treatment of Barrett's esophagus by endoscopic argon plasma coagulation. Endoscopy. 1997;29:751-753.
17. Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high grade dysplasia within Barrett's esophagus. Gastrointest Endosc. 2000;52:328-332.
18. Ludwig DJ, Thirlby RC, Low DE. A prospective evaluation of dietary status and symptoms after near total esophagectomy without gastric emptying procedure. Am J Surg. 2001;181:454-458.
19. Traverso LW, Shinchi H, Low DE. Useful benchmarks to evaluate outcomes after esophagectomy and pancreaticoduodenostomy. Am J Surg. 2004;187:604-608.
20. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). Med Care. 1992;30:473-483.
21. Levine DS, Haggit RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology. 1993;105:40-50.
22. Wang KK, Sampliner RE. Mucosal ablation therapy of Barrett's esophagus. Mayo Clin Proc. 2001;76:433-437.
23. Overholt BF, Panjehpour M, Haydeck JM. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc. 1999;49:1-7.
24. Van Laethem JL, Cremer M, Peny MO, et al. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid-term results. Gut. 1998;43:747-751.
25. Krishnadath KK, Wang KK, Taniguchi K, et al. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology. 2000;119:624-630.
26. Van Laethem JL, Peny MO, Salmon I, et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut. 2000;46:574-577.
27. Krishnadath KK, Reid BJ, Wang KK. Biomarkers in Barrett esophagus. Mayo Clin Proc. 2001;76:438-446.
28. Tseng EE, Wu TT, Yeo CJ, Heitmiller RF. Barrett's esophagus with high grade dysplasia: surgical results and long-term outcome-an update. J Gastrointest Surg. 2003;7:164-171.
29. Liu S, Carpenter RL, Neal JM. Epidural anesthesia and analgesia. Anesthesiology. 1995;82:1474-1506.